Nectin Therapeutics

Developing immuno-oncology and ADC breakthrough therapies

Nectin Therapeutics was founded in 2017, is headquartered in Jerusalem, Israel, and has $46.4M in recorded funding across 4 rounds.

Headquarters
Jerusalem
Founded
2017
Business Model
B2B
Total Funding
$46.4M
Last Round
$10.0M Series AJan 2024
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 7 investors for this company. The full record is or through the API.

About

The Company, established in 2017 is based on seminal research conducted at the Hebrew University of Jerusalem and the University of Rijeka. Our technology addresses major escape mechanisms of current IO therapies through a diverse pipeline of novel monoclonal antibodies (mAbs) and antibody-drug-conjugates (ADCs). In late 2022 we launched phase 1 of a clinical trial for NTX1088, our first-in-class anti-PVR targeted immunotherapy for the treatment of patients with advanced solid tumors together with MD Anderson and entered into a clinical trial collaboration agreement with MSD (Merck).

Summary

Nectin Therapeutics is a Biotech company based in Jerusalem, Israel, founded in 2017. It has raised $46.4M in total across 4 rounds, most recently a $10.0M Series A round in Jan 2024. Investors include aMoon, Cancer Focus Fund and Guangzhou Sino-Israel Bio-Industry Investment Fund.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries A2024 (est.)
$10.0M

Sign up to see all 4 events

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Nectin Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/nectin-therapeutics"><img src="https://indexed.vc/api/badge/company/nectin-therapeutics" alt="Nectin Therapeutics on Indexed.vc" width="260" height="76" /></a>